COMMUNIQUÉS West-GlobeNewswire

Resmed Announces Agreement to Sell MatrixCare Business
07/07/2026
Sharpens Resmed’s focus on high-growth sleep and connected care markets SAN DIEGO, July 07, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and [...]
AdCare Rhode Island Opens New Program to Support Recovery and Accountability Following Impaired Driving Offenses
07/07/2026
NORTH KINGSTOWN, R.I., July 07, 2026 (GLOBE NEWSWIRE) -- AdCare Rhode Island, a leading provider of addiction treatment in South County , has launched a new outpatient DUI/refusal program for eligible first- and second- [...]
ARS Pharmaceuticals Announces CEO Succession
07/07/2026
Richard Lowenthal, Chief Executive Officer, Transitioning following More than a Decade of Leadership Since Co-Founding the Company Donn Casale, President, Appointed Chief Executive Officer and Director SAN DIEGO, July [...]
Erdem Hospital Launches UK Patient Community with First London Wellness Event
07/07/2026
The Istanbul-based healthcare group hosted its first UK wellness gathering in London, bringing together former patients and individuals interested in wellbeing for an afternoon of movement, relaxation and connection [...]
Legend Senior Living Deepens Commitment to Oklahoma Seniors with The Stonehaven of Oklahoma City
07/07/2026
WICHITA, Kan., July 07, 2026 (GLOBE NEWSWIRE) -- Legend Senior Living will welcome The Stonehaven of Oklahoma City, formerly known as The Harrison, to its growing family of senior living communities. Located in south [...]
Catalyst MedTech Announces Channel Partnership with APQ Health to Expand Access to Advanced Cardiac CT Analysis
07/07/2026
PITTSBURGH, July 07, 2026 (GLOBE NEWSWIRE) -- Catalyst MedTech, a leader in nuclear medicine and molecular imaging solutions, today announced a strategic channel partnership with APQ Health to expand access to advanced [...]
Procès verbal AGE - 29 juin 2026
07/07/2026
Procès verbal de l'AGE du 29 juin 2026. Pièce jointe IBA - AGE 2026-06-29 définitive Ion Beam Applications
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2026
07/07/2026
Nombre total de droits de vote et d’actions composant le capital social au 30 juin 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2026
07/07/2026
Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Ipsen - Bilan semestriel - 30 juin 2026
07/07/2026
Bilan semestriel du contrat de liquidité entre IPSEN et NATIXIS ODDO BHF PARIS, FRANCE, 07 JUILLET 2026 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce aujourd'hui qu’au titre du contrat de liquidité confié par IPSEN S.A [...]
Ipsen - Half year statement - 2026 06 30
07/07/2026
Half-year statement of the liquidity agreement between IPSEN SA and NATIXIS ODDO BHF PARIS, 07 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that under the liquidity agreement entrusted by IPSEN S.A. to [...]
Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy
07/07/2026
TRUTAKNA is the first and only available therapy that binds both B-cell activating factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), addressing the immunological drivers at the source of IgA nephropathy (IgAN [...]
Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization
07/07/2026
VANCOUVER, British Columbia, July 07, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes
07/07/2026
MIAMI, July 07, 2026 (GLOBE NEWSWIRE) -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical [...]
Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1
07/07/2026
Completion of enrollment anticipated within 12 months GALILEO-3 is intended to support the registration of FLT201 in the adult GD1 population LONDON, July 07, 2026 (GLOBE NEWSWIRE) -- Spur Therapeutics today announced [...]
Nu-Tek BioSciences présente ses innovations en matière de nutriments cellulaires et son expertise en matières premières lors de la conférence SIMB 2026
07/07/2026
Nu-Tek présentera des données démontrant comment ses nutriments pour milieux de culture sans composants d’origine animale améliorent le rendement, optimisent les procédés et renforcent la sécurité d’approvisionnement [...]
Nu-Tek BioSciences Present Cell Nutrient Innovation, Raw Material Expertise at SIMB 2026
07/07/2026
Nu-Tek will present data showing how its animal-free culture media nutrients improve yield, enhance processes, and strengthen supply security for bioprocessing. MINNETONKA, Minn., July 07, 2026 (GLOBE NEWSWIRE) -- Nu- [...]
Daxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, Texas
07/07/2026
Daxor to Showcase How BVA Provides the Objective Plasma and Red Blood Cell Data Needed to Target Dysautonomia Therapy Oak Ridge, TN, July 07, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader [...]
SkinStylus® Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
07/07/2026
SkinStylus SteriLock MicroSystem Now the Only Microneedling Device with Indications for Facial Acne Scars, Periorbital Wrinkles, and Abdominal Scars Hydrafacial Treatment Pairing Continues to Drive Adoption of [...]

Pages